Frequently asked questions

The European Medicines Agency (EMA) has published answers to the most frequently asked questions (FAQs) it receives.

If the answer to your question is not here, please send a question to EMA.

Journalists and other representatives of the press should contact the Agency's press office.

For the FAQs in other European Union languages, see Translations.

For questions specifically related to EMA’s work in the context of the COVID-19 pandemic, see:

EMA is not involved in advising on travel requirements in the European Union (EU), such as vaccination, quarantine or testing for travellers. 

Decisions about which COVID-19 vaccines are included, for example, in the EU Digital COVID Certificate, are taken by the EU Member States. EMA is in charge of the scientific evaluation of vaccines for EU marketing authorisation. The acceptability criteria for travel purposes are broader and can include, for example, World Health Organization (WHO) listed vaccines that have not necessarily undergone the EMA process of authorisation.

Official information on this topic is available in all EU languages at: 

Questions about the Agency

Questions about this website

Questions about medicines

Questions about the evaluation of other substances

Questions about conflicts of interest and transparency

Questions about the availability of medicines

Questions about pricing, advertising, sales and patents

Questions about medical advice

Questions about clinical trials

Questions about fees

Translations

How useful was this page?

Add your rating
Average
28 ratings
30 ratings
24 ratings
16 ratings
62 ratings